Essential antiarrhythmic drug accessibility worldwide: a multi-survey study and comprehensive evaluation of access and supply challenges. [PDF]
Postema PG +15 more
europepmc +1 more source
Response to the letter regarding 'Outcomes of functional ventricular tachycardia ablation vs. medical therapy in Chagas cardiomyopathy patients with implantable cardioverter-defibrillators: a competing risks analysis'. [PDF]
do Carmo AAL +2 more
europepmc +1 more source
Early catheter ablation vs. antiarrhythmic drugs in treatment-naïve ischaemic ventricular tachyarrhythmias: a meta-analysis of randomized controlled trials. [PDF]
Façanha TM +5 more
europepmc +1 more source
Catheter Ablation as an Early Rhythm-control Strategy in Patients with Atrial Fibrillation and Heart Failure. [PDF]
Alkalbani M, Sandesara C.
europepmc +1 more source
An Updated Systematic Review and Meta-Analysis of the Efficacy and Safety of Catheter Ablation in Comparison to Antiarrhythmic Drugs for Managing Atrial Fibrillation. [PDF]
Garg K +7 more
europepmc +1 more source
Temporary Rhythm Control with Flecainide in Atrial Fibrillation-Related Conversion Pauses Prior to Catheter Ablation: A Case of Successful Pharmacological Bridging. [PDF]
Skakun O +8 more
europepmc +1 more source
Cardiac α4β2 nicotinic receptors as a therapeutic target for fatal ventricular arrhythmias. [PDF]
Xie D +21 more
europepmc +1 more source
Management of patients with electrical storm at Kyorin University. [PDF]
Junkrasien C +3 more
europepmc +1 more source
Pharmacological Insights and Clinical Challenges of Wenxin Keli in Arrhythmia Treatment. [PDF]
Fu J +8 more
europepmc +1 more source
Association of anti-catecholaminergic antiarrhythmic drugs with survival in sepsis-associated new-onset atrial fibrillation. [PDF]
Huang X +4 more
europepmc +1 more source

